From: Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/SDF-1 expression in the metastatic niches
IntDen
StdDev
%Area
Secondary negative control
32.97**
30.27
0.3
Balb/C with no tumor
1001.25*
26.59
1.23
SKG with no tumor
1154.60*
25.53
1.98
SKG + BC + IgG
4249.27
21.13
25.49
SKG + BC + anti-IL-17A
1179.99*
24.97
4.49